EMA Says Benefits Outweigh The Clots Potentially Linked To Johnson & Johnson Vaccine

The European Medicines Agency concluded there is a possible link between the Johnson & Johnson vaccine and rare, unusual blood clots, saying the benefits of the vaccine outweigh the very rare risks.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Ad Block Detected

Welcome to Mediexpose, Please support our journalism by allowing ads. With support from readers like you, we can continue to deliver the best. You can support us free by simply allowing ads.